Meek David D.
SEC insider (Form 3/4/5 filer). CIK 0001555337. Director at Cullinan Therapeutics, Inc. (CGEM) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in AMSTERDAM.
Companies Meek David D. has filed insider reports for
- Cullinan Therapeutics, Inc. (CGEM): Director
- uniQure N.V. (QURE): Director
Meek David D.
CIK: 0001555337
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 16, 2026CGEM
Cullinan Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
25.3K shares- - Jun 11, 2026QURE
uniQure N.V.
SaleDirect2K shares at avg. $27.06$54K - Jun 10, 2026QURE
uniQure N.V.
AwardDirect7.6K shares- - Jun 20, 2025QURE
uniQure N.V.
SaleDirect2.1K shares at avg. $14.45$31K - Jun 12, 2025CGEM
Cullinan Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
38.5K shares- - Jun 11, 2025QURE
uniQure N.V.
AwardDirect8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 |  CGEM Cullinan Therapeutics, Inc. | Award Stock Option (Right to Buy) | 25,319 | - | - | Direct |
| Jun 11, 2026 |  QURE uniQure N.V. | Sale | 1,993 | $27.06 | $53,931 | Direct |
| Jun 10, 2026 | QURE uniQure N.V. | Award | 7,550 | - | $0 | Direct |
| Jun 20, 2025 | QURE uniQure N.V. | Sale | 2,112 | $14.45 | $30,518 | Direct |
| Jun 12, 2025 | CGEM Cullinan Therapeutics, Inc. | Award Stock Option (Right to Buy) | 38,513 | - | - | Direct |
| Jun 11, 2025 | QURE uniQure N.V. | Award | 7,970 | - | - | Direct |
1-6 of 6 transactions